Home » Topics » Regulatory » Patents

Patents
RSS

BioWorld MedTech Patent Highlights: Week 42

From Current Patent Gazette

Oct. 29, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Bayer describes new anthelmintic compounds

Oct. 29, 2021

Camp Therapeutics identifies new antibacterial peptides

Oct. 29, 2021

Agios Pharmaceuticals, University of Michigan present menin/MLL interaction inhibitors

Oct. 29, 2021

New IL-17 modulators discovered at UCB

Oct. 29, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents HBV HBsAg secretion inhibitors

Oct. 29, 2021

New ENPP1 inhibitors discovered at Betta Pharmaceuticals

Oct. 28, 2021

ADAMTS5 inhibitors patented by Shenzhen Salubris Pharmaceuticals

Oct. 28, 2021

Medshine Discovery presents new DNA-dependent protein kinase inhibitors

Oct. 28, 2021

TGF-beta receptor type-1 inhibitors discovered at Theravance Biopharma

Oct. 28, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...